Stone Summit Wealth’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
Stone Summit Wealth's AMGN Position: Q1 2026 in Review
Stone Summit Wealth increased its Amgen (AMGN) stake by 3% in Q1 2026, buying an estimated $24.2K and bringing the position to 2,299 shares worth $809K. The position accounts for 0.23% of the portfolio, ranked #72.
Stone Summit Wealth first reported a position in AMGN in Q1 2022 and has held it in 17 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Stone Summit Wealth held 2,299 shares of Amgen worth $809K as of Q1 2026.
- Stone Summit Wealth bought 68 Amgen shares in Q1 2026, an estimated $24.2K.
- Amgen made up 0.23% of Stone Summit Wealth's portfolio in Q1 2026, its #72 holding.
- Stone Summit Wealth first reported a position in Amgen in Q1 2022 and has held it in 17 quarters since.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Stone Summit Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.